1. Home
  2. PRTH vs BBNX Comparison

PRTH vs BBNX Comparison

Compare PRTH & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRTH

Priority Technology Holdings Inc.

HOLD

Current Price

$6.30

Market Cap

602.0M

Sector

Technology

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.06

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTH
BBNX
Founded
2005
2015
Country
United States
United States
Employees
1200
423
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.0M
493.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRTH
BBNX
Price
$6.30
$16.06
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$8.33
$23.80
AVG Volume (30 Days)
450.0K
994.2K
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.76
$34.90
Revenue Next Year
$6.79
$34.63
P/E Ratio
$10.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.44
$8.80
52 Week High
$8.59
$32.71

Technical Indicators

Market Signals
Indicator
PRTH
BBNX
Relative Strength Index (RSI) 42.30 50.51
Support Level $5.33 $9.34
Resistance Level $6.75 $32.52
Average True Range (ATR) 0.29 1.17
MACD -0.12 -0.25
Stochastic Oscillator 18.02 18.16

Price Performance

Historical Comparison
PRTH
BBNX

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a fintech company that provides payment and banking-related solutions, including services for collecting, storing, lending, and transferring money for businesses. The company has three reportable segments: i) Merchant Solutions: Provides full-service acquiring and payment-enabled solutions for B2C transactions, ii) Payables: Provides AP automation solutions to corporations, software partners and FIs in addition to improving cash flows by providing instant access to working capital and iii) Treasury Solutions: Provides embedded finance and BaaS solutions to customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments. The majority of the company's revenue is derived from the Merchant Solutions segment.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: